Proteros: Change of personnel

Proteros announces election of Prof. Eric-Paul Pâques, CEO of Grünenthal

21-Feb-2014 - Germany

Proteros biostructures announced that its shareholders confirmed the appointment of Prof. Eric-Paul Pâques as a new member of the Supervisory Board. Prof. Pâques is presently CEO and Chairman of the Corporate Executive Board of Grünenthal, an international research-based pharmaceutical company headquartered in Aachen, Germany. Prior to his more than 20 years at Grünenthal, he worked as the Head of Research at Behringwerke AG, in Germany. Prof. Pâques received a doctorate in Chemistry from the Université Catholique de Louvain.

'We are delighted to have Eric-Paul joining our board' commented Dave Lemus, Chairman of the Supervisory Board of Proteros. 'His extensive experience in the pharmaceutical industry will prove invaluable to Proteros as the company accelerates its transition to the next phase of its development.'

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances